A rare-disease entrepreneur follows an unconventional drug development path
Monday, October 15, 2018 - 01:24
in Mathematics & Economics
In 2012, Ethan Perlstein challenged the academic status quo. Now as CEO of the start-up Perlara, can he do the same for the biotech industry?